For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Synthetic peptide within Human CD105 aa 1-200. The exact sequence is proprietary.
Database link: P17813
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
This product is a recombinant rabbit monoclonal antibody.
Our Abpromise guarantee covers the use of ab170943 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/1000 - 1/5000. Predicted molecular weight: 70 kDa.|
|IHC-P||1/250 - 1/500.|
ab170943 showing +ve staining in Human lung carcinoma-vessels tissue.
ab170943 showing +ve staining in Human normal tonsil-vessels tissue.
ab170943 showing +ve staining in Human urinary bladder transitional carcinoma, vessels tissue.
ab170943 showing +ve staining in Human normal uterus, vessels tissue.
Immunohistochemical analysis of paraffin-embedded Human placenta tissue labeling CD105 with ab170943 at 1/250 dilution.
Immunohistochemical analysis of paraffin-embedded Human cervical carcinoma tissue labeling CD105 with ab170943 at 1/250 dilution.
ab170943 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"